Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says

Executive Summary

Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19

You may also be interested in...



Synergies Without The Merger: Pfizer Sees $4 Bil. In Cost Cutting By 2008

Pfizer is launching an internal cost-cutting plan that will rival the synergies achieved by its 2003 acquisition of Pharmacia

Synergies Without The Merger: Pfizer Sees $4 Bil. In Cost Cutting By 2008

Pfizer is launching an internal cost-cutting plan that will rival the synergies achieved by its 2003 acquisition of Pharmacia

Novartis To Maintain Sales Force In Face Of Potential Competitor Cutbacks

Novartis' decision to maintain its current sales force level could reflect the company's confidence in the continued growth of its pharmaceutical business

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045280

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel